TABLE 1.
Characteristics of the Brain Tumor Sample
| n (%) | Range | Mean (SD) | |
|---|---|---|---|
| Child sex | |||
| Male | 32 (44.4) | — | — |
| Female | 40 (55.6) | — | — |
| Child race | |||
| White | 46 (63.9) | — | — |
| Black | 11 (15.3) | — | — |
| Hispanic | 3 (4.2) | — | — |
| Asian | 3 (4.2) | — | — |
| Hawaiian | 1 (1.4) | — | — |
| Multi-racial | 3 (4.2) | — | — |
| Not reported | 3 (4.2) | — | — |
| Other | 2 (2.8) | — | — |
| Age at diagnosis (y) | — | 0.5-18.5 | 7.7 (5.0) |
| Age at evaluation (y) | — | 7.2-21.8 | 13.7 (4.0) |
| Time since diagnosis (y) | — | 2.0-16.2 | 6.0 (4.0) |
| NPS | — | 0-10 | 4.8 (2.4) |
| Tumor Location | |||
| Infratentorial | 35 (48.6) | — | — |
| Supratentorial | 18 (25.0) | — | — |
| Midbrain | 19 (26.4) | — | — |
| Lobule* | |||
| Frontal | 10 (13.9) | — | — |
| Parietal | 2 (2.8) | — | — |
| Temporal | 4 (5.6) | — | — |
| Occipital | 3 (4.2) | — | — |
| Midbrain | 19 (26.4) | — | — |
| Cerebellum | 35 (48.6) | — | — |
| Pathology | |||
| Astrocytoma | 16 (22.2) | — | — |
| ATRT | 1 (1.4) | — | — |
| Craniopharyngioma | 8 (11.1) | — | — |
| Ependymoma | 8 (11.1) | — | — |
| Gangliocytoma | 3 (4.2) | — | — |
| Glioma | 14 (19.4) | — | — |
| Germinoma | 4 (5.6) | — | — |
| Central Nervous System Neuroblastoma | 2 (2.8) | — | — |
| Medulloblastoma | 8 (11.1) | — | — |
| Meningioma | 1 (1.4) | — | — |
| Papilloma | 2 (2.8) | — | — |
| Pineoblastoma | 2 (2.8) | — | — |
| PNET | 3 (4.2) | — | — |
| Treatment Completed | |||
| Resection | 61 (84.7) | — | — |
| Chemotherapy | 38 (52.8) | — | — |
| Radiation | 29 (40.3) | — | — |
*
Value greater than 100% as one participant had multi-lobule involvement.
ATRT indicates Atypical Teratoid Rhabdoid Tumor; NPS, Neurological Predictor Scale score cumulative neuro-oncologic risk score based upon history of hydrocephalus, seizures, endocrinopathies, chemotherapy, extent and number of neuro-surgeries, and type of radiation therapy; PNET, Primitive neuroectodermal tumor.